Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons

Journal of Psychopharmacology

Volumn 24, Issue 1, 2010, Pages 39-50

  Ghanbari, R ^a   El Mansari, M ^a   Blier, P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bupropion; Electrophysiology; Escitalopram; Norepinephrine; Serotonin

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; ELECTROPHYSIOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTORECEPTORS; BUPROPION; CITALOPRAM; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROPHYSIOLOGY; MALE; NEURONS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 76249084105     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108095714     Document Type: Article

References (44)

1. Albert, PR, Lemonde, S. (2004) 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10: 575-593.
2. Aman, TK, Shen, RY, Haj-Dahmane, S. (2007) D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance. J Pharmacol Exp Ther 320: 376-385.
3. Argyelan, M., Szabo, Z., Kanyo, B., Tanacs, A., Kovacs, Z., Janka, Z., et al. (2005) Dopamine transporter availability in medication free and in bupaopion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89: 115-123.
4. Blier, P., de Montigny, C. (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3: 1270-1278.
5. Blier, P., de Montigny, C. (1985) Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16: 949-955.
6. Blier, P., de Montigny, C. (1987 a) Short-term lithium treatment enhances responsiveness of postsynaptic 5-HT1A receptors without altering 5-HT autoreceptor sensitivity: an electrophysiological study in the rat brain. Synapse 1: 225-232.
7. Blier, P., de Montigny, C. (1987 b) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480.
8. Blier, P., de Montigny, C., Tardif, D. (1984) Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology (Berl) 84: 242-249.
9. Chaput, Y., de Montigny, C., Blier, P. (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 333: 342-348.
10. Cusack, B., Nelson, A., Richelson, E. (1994) Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl) 114: 559-565.
11. Daly, JJ, Prudic, J., Devanand, DP, Nobler, MS, Lisanby, SH, et al. (2001) ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord 3: 95-104.
12. Dawe, GS, Huff, KD, Vandergriff, JL, Sharp, T., öNeill, MJ, Rasmussen, K. (2001) Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50: 510-520.
13. DeBattista, C. (2006) Augmentation and combination strategies for depression. J Psychopharmacol 20: 11-18.
14. Dong, J., Blier, P. (2001) Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology (Berl) 155: 52-57.
15. Dremencov, E., El Mansari, M., Blier, P. (2007) Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain. Biol Psychiatry 61: 671-678.
16. El Mansari, M., Sanchez, C., Chouvet, G., Renaud, B., Haddjeri, N. (2005) Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30: 1269-1277.
17. Gartside, SE, Hajos-Korcsok, E., Bagdy, E., Harsing, LG, Sharp, T., Hajos, M. (2000) Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 98: 295-300.
18. Gobbi, G., Slater, S., Boucher, N., Debonnel, G., Blier, P. (2003) Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol 23: 233-239.
19. Grace, AA, Bunney, BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4: 2877-2890.
20. Guiard, BP, El Mansari, M., Merali, Z., Blier, P. (2008) Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 11: 625-639.
21. Hajos, M., Sharp, T. (1996) Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res 740: 162-168. (Pubitemid 26411295)
22. Hardebo, JE (1992) Influence of impulse pattern on noradrenaline release from sympathetic nerves in cerebral and some peripheral vessels. Acta Physiol Scand 144: 333-339.
23. Hensler, JG (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72: 1665-1682.
24. Kugaya, A., Seneca, NM, Snyder, PJ, Williams, SA, Malison, RT, Baldwin, RM, et al. (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28: 413-420.
25. Learned-Coughlin, SM, Bergstorm, M., Savitcheva, I., Ascher, J., Schmith, VD, Langstorm, B. (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54: 800-805.
26. Li, SX, Perry, KW, Wong, DT (2002) Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology 42: 181-190.
27. Marwaha, J., Aghajanian, GK (1982) Relative potencies of α1 and α2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther 222: 287-293.
28. Meyer, JH, Goulding, VS, Wilson, AA, Hussey, D., Christensen, BK, Houle, S. (2002) Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) 163: 102-105.
29. Millan, MJ, Rivet, JM, Gobert, A., Canton, H., Veiga, S., Bervoets, K. (1994) 5-HT1A receptors and the tail-flick response. VI. Intrinsic α1A-adrenoceptor antagonist properties can mask the actions of 5HT1A receptor agonists in the spontaneous tail-flick paradigm. J Pharmacol Exp Ther 269: 121-131.
30. Mischoulon, D., Nierenberg, AA, Kizilbash, L., Rosenbaum, JF, Fava, M. (2000) Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry 45: 476-481.
31. Mork, A., Kreilgaard, M., Sanchez, C. (2003) The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Neuropharmacology 45: 167-173.
32. Owens, MJ, Knight, DL, Nemeroff, CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50: 345-350.
33. Piacentini, MF, Clinckers, R., Meeusen, R., Sarre, S., Ebinger, G., Michotte, Y. (2003) Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol 95: 652-656.
34. Pineyro, G., Blier, P. (1999) Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51: 533-591.
35. Seager, MA, Huff, KD, Barth, VN, Phebus, LA, Rasmussen, K. (2004) Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity. Biol Psychiatry 55: 1103-1109.
36. Stewart, JW (2007) Combined bupropion-escitalopram as first-line treatment for depression. Biol Psychiatry 61 (Suppl. 8). 629.
37. Svensson, TH, Bunney, BS, Aghajanian, GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 92: 291-306.
38. Szabo, ST, Blier, P. (2000) Effect of accute and sustained administration of reboxetine on locus coeruleus noradrenergic and dorsal 5-HT neurons. Int J neuropsychopharmacol 3: S218 - S219.
39. Szabo, ST, Blier, P. (2001) Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci 13: 2077-2087.
40. Szabo, ST, Blier, P. (2002) Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT2A receptor antagonism on the firing activity of norepinephrine neurons. J Pharmacol Exp Ther 302: 983-991.
41. Szabo, ST, de Montigny, C., Blier, P. (1999) Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol 126: 568-571.
42. Tatsumi, M., Groshan, K., Blakely, RD, Richelson, E. (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-258.
43. Thase, ME, Entsuah, AR, Rudolph, RL (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178: 234-241.
44. Trivedi, MH, Fava, M., Wisniewski, SR, Thase, ME, Quitkin, F., Warden, D., et al. (2006) Medication augmentation after the failure of SSRIs for depression. N Engl J Med 354: 1243-1252.